Anti-depressants and SuicideJens Ludwig, Dave E. Marcotte, Karen Norberg
NBER Working Paper No. 12906 ---- Acknowledgements ----- The research reported here was supported by small grants to Marcotte and Ludwig from UMBC and the Georgetown University Graduate School of Arts and Sciences. Norberg was supported with funding from NIH grant 5K08MH001809, and the Center for Health Policy at Washington University. None of the authors have received funding from pharmaceutical companies or other entities with financial interests relevant to the paper's topic. Thanks to Jonathan Caulkins, Philip Cook, Jeff DeSimone, William Dickens, Carlos Dobkin, Dan Feenberg, Ted Gayer, Chris Hansen, Jeffrey Kling, Alain Lesage, Byron Lutz, Sara Markowitz, James Mercy, Matthew Miller, Steve Pischke, Steve Raphael, David Salkever, Eric Slade, Betsey Stevenson, Justin Wolfers, and seminar participants at the CDC, NBER and APPAM for assistance and helpful comments. IMS Health, Inc. was very generous and helpful in providing necessary data. Steve Hemelt and Ozlen Luznar provided excellent research assistance. Comments can be directed to any of the paper's authors at ludwigj@georgetown.edu, marcotte@umbc.edu, or norberg@nber.org. Any errors and all opinions are of course our own. The views expressed herein are those of the author(s) and do not necessarily reflect the views of the National Bureau of Economic Research. |

Contact Us








